Phase 1 Study to Assess Safety, Tolerability, PD, PK, Immunogenicity of IV NTR-441 Solution in Healthy Volunteers and COVID-19 Patients
Clinical trial NCT04941183 · TERMINATED
Trial details
- NCT number
- NCT04941183
- Sponsor
- Neutrolis
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-14
- Primary completion
- 2022-12-12
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.